Glaxo recalls flu vaccine due to potency problem
GlaxoSmithKline is recalling remaining doses of a popular four-in-one flu vaccine because of effectiveness problems.
Apr 17, 2015
0
3
GlaxoSmithKline is recalling remaining doses of a popular four-in-one flu vaccine because of effectiveness problems.
Apr 17, 2015
0
3
Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC.
Mar 29, 2015
0
14
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
Mar 27, 2015
0
7
(AP)—GlaxoSmithKline's diet pill, alli (ow-LEYE'), is now back in most U.S. stores.
Feb 25, 2015
0
2
GlaxoSmithKline's net profits almost halved last year, hit partly by a large Chinese fine following a bribery probe, the British drugmaker said Wednesday.
Feb 4, 2015
0
4
The World Health Organization says the two leading Ebola vaccines appear safe and will soon be tested in healthy volunteers in West Africa.
Jan 9, 2015
0
11
Hundreds of British drugmaker GlaxoSmithKline's 17,000 U.S.-based employees will lose their jobs by the end of next year under the pharmaceutical industry's latest restructuring.
Dec 4, 2014
0
0
President Barack Obama's initiative to study the brain and improve treatment of conditions like Alzheimer's and autism was given a boost Tuesday with the announcement of more than $300 million in funds.
Oct 1, 2014
0
0
(HealthDay)—For patients with eosinophilic asthma, mepolizumab has a glucocorticoid-sparing effect and reduces exacerbations when administered intravenously or subcutaneously, according to two studies published online Sept. ...
Sep 9, 2014
0
0
Safety trials on an Ebola vaccine are being fast-tracked, meaning it could be given to healthy volunteers as early as September, researchers said Thursday.
Aug 28, 2014
0
0